These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, Sharma S. Oncogene; 1995 Oct 19; 11(8):1615-22. PubMed ID: 7478586 [Abstract] [Full Text] [Related]
23. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Dole M, Nuñez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP. Cancer Res; 1994 Jun 15; 54(12):3253-9. PubMed ID: 8205548 [Abstract] [Full Text] [Related]
24. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA. Cancer Res; 1993 Jul 15; 53(14):3321-6. PubMed ID: 8324744 [Abstract] [Full Text] [Related]
25. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Saltzman A, Munro R, Searfoss G, Franks C, Jaye M, Ivashchenko Y. Exp Cell Res; 1998 Jul 10; 242(1):244-54. PubMed ID: 9665822 [Abstract] [Full Text] [Related]
30. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Brown DM, Warner GL, Alés-Martínez JE, Scott DW, Phipps RP. Clin Immunol Immunopathol; 1992 Jun 10; 63(3):221-9. PubMed ID: 1623642 [Abstract] [Full Text] [Related]
31. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A, Pfaff P, Lange W, Finke J. Cytokines Mol Ther; 1996 Mar 10; 2(1):21-8. PubMed ID: 9384686 [Abstract] [Full Text] [Related]
33. Role of bcl-2 and IL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. A cooperative regulation model for B cell clonal deletion. Kamesaki H, Zwiebel JA, Reed JC, Cossman J. J Immunol; 1994 Apr 01; 152(7):3294-305. PubMed ID: 8144916 [Abstract] [Full Text] [Related]
35. E-series prostaglandins are potent growth inhibitors for some B lymphomas. Phipps RP, Lee D, Schad V, Warner GL. Eur J Immunol; 1989 Jun 01; 19(6):995-1001. PubMed ID: 2546781 [Abstract] [Full Text] [Related]
37. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B. Cancer Res; 2004 Oct 01; 64(19):7117-26. PubMed ID: 15466208 [Abstract] [Full Text] [Related]
38. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. Cancer Res; 2005 Jan 01; 65(1):264-76. PubMed ID: 15665303 [Abstract] [Full Text] [Related]
39. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW, Huang HC. Br J Pharmacol; 1998 Jul 01; 124(6):1029-40. PubMed ID: 9720770 [Abstract] [Full Text] [Related]